265 related articles for article (PubMed ID: 30194907)
21. Prevalence of rearrangements in the 22q11.2 region and population-based risk of neuropsychiatric and developmental disorders in a Danish population: a case-cohort study.
Olsen L; Sparsø T; Weinsheimer SM; Dos Santos MBQ; Mazin W; Rosengren A; Sanchez XC; Hoeffding LK; Schmock H; Baekvad-Hansen M; Bybjerg-Grauholm J; Daly MJ; Neale BM; Pedersen MG; Agerbo E; Mors O; Børglum A; Nordentoft M; Hougaard DM; Mortensen PB; Geschwind DH; Pedersen C; Thompson WK; Werge T
Lancet Psychiatry; 2018 Jul; 5(7):573-580. PubMed ID: 29886042
[TBL] [Abstract][Full Text] [Related]
22. Risk of Psychiatric Disorders Among Individuals With the 22q11.2 Deletion or Duplication: A Danish Nationwide, Register-Based Study.
Hoeffding LK; Trabjerg BB; Olsen L; Mazin W; Sparsø T; Vangkilde A; Mortensen PB; Pedersen CB; Werge T
JAMA Psychiatry; 2017 Mar; 74(3):282-290. PubMed ID: 28114601
[TBL] [Abstract][Full Text] [Related]
23. Musical auditory processing, cognition, and psychopathology in 22q11.2 deletion syndrome.
Gao L; Tang SX; Yi JJ; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Calkins ME; Gur RE
Am J Med Genet B Neuropsychiatr Genet; 2018 Dec; 177(8):765-773. PubMed ID: 30444066
[TBL] [Abstract][Full Text] [Related]
24. Sex differences in the behavior of children with the 22q11 deletion syndrome.
Sobin C; Kiley-Brabeck K; Monk SH; Khuri J; Karayiorgou M
Psychiatry Res; 2009 Mar; 166(1):24-34. PubMed ID: 19217670
[TBL] [Abstract][Full Text] [Related]
25. Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome.
Vorstman JA; Breetvelt EJ; Duijff SN; Eliez S; Schneider M; Jalbrzikowski M; Armando M; Vicari S; Shashi V; Hooper SR; Chow EW; Fung WL; Butcher NJ; Young DA; McDonald-McGinn DM; Vogels A; van Amelsvoort T; Gothelf D; Weinberger R; Weizman A; Klaassen PW; Koops S; Kates WR; Antshel KM; Simon TJ; Ousley OY; Swillen A; Gur RE; Bearden CE; Kahn RS; Bassett AS;
JAMA Psychiatry; 2015 Apr; 72(4):377-85. PubMed ID: 25715178
[TBL] [Abstract][Full Text] [Related]
26. A neurogenetic model for the study of schizophrenia spectrum disorders: the International 22q11.2 Deletion Syndrome Brain Behavior Consortium.
Gur RE; Bassett AS; McDonald-McGinn DM; Bearden CE; Chow E; Emanuel BS; Owen M; Swillen A; Van den Bree M; Vermeesch J; Vorstman JAS; Warren S; Lehner T; Morrow B
Mol Psychiatry; 2017 Dec; 22(12):1664-1672. PubMed ID: 28761081
[TBL] [Abstract][Full Text] [Related]
27. The interaction between neurocognitive functioning, subthreshold psychotic symptoms and pharmacotherapy in 22q11.2 deletion syndrome: A longitudinal comparative study.
Weinberger R; Weisman O; Guri Y; Harel T; Weizman A; Gothelf D
Eur Psychiatry; 2018 Feb; 48():20-26. PubMed ID: 29331595
[TBL] [Abstract][Full Text] [Related]
28. Social skills and associated psychopathology in children with chromosome 22q11.2 deletion syndrome: implications for interventions.
Shashi V; Veerapandiyan A; Schoch K; Kwapil T; Keshavan M; Ip E; Hooper S
J Intellect Disabil Res; 2012 Sep; 56(9):865-78. PubMed ID: 21883601
[TBL] [Abstract][Full Text] [Related]
29. Longitudinal Psychiatric and Developmental Outcomes in 22q11.2 Deletion Syndrome: A Systematic Review.
Jhawar N; Brown MJ; Cutler-Landsman D; Kates WR; Angkustsiri K; Antshel KM
J Dev Behav Pediatr; 2021 Jun-Jul 01; 42(5):415-427. PubMed ID: 34110308
[TBL] [Abstract][Full Text] [Related]
30. [Spectrum of neuropsychiatric features associated with velocardiofacial syndrome (Deletion 22q11.2)].
Sieberer M; Runte I; Wilkening A; Pabst B; Ziegenbein M; Haltenhof H
Fortschr Neurol Psychiatr; 2006 May; 74(5):263-74. PubMed ID: 16758538
[TBL] [Abstract][Full Text] [Related]
31. Transcriptome Profiling of Peripheral Blood in 22q11.2 Deletion Syndrome Reveals Functional Pathways Related to Psychosis and Autism Spectrum Disorder.
Jalbrzikowski M; Lazaro MT; Gao F; Huang A; Chow C; Geschwind DH; Coppola G; Bearden CE
PLoS One; 2015; 10(7):e0132542. PubMed ID: 26201030
[TBL] [Abstract][Full Text] [Related]
32. Predicting Cognition and Psychosis in Young Adults With 22q11.2 Deletion Syndrome.
Antshel KM; Fremont W; Ramanathan S; Kates WR
Schizophr Bull; 2017 Jul; 43(4):833-842. PubMed ID: 27798222
[TBL] [Abstract][Full Text] [Related]
33. Exploring pathway interactions to detect molecular mechanisms of disease: 22q11.2 deletion syndrome.
Shin W; Kutmon M; Mina E; van Amelsvoort T; Evelo CT; Ehrhart F
Orphanet J Rare Dis; 2023 Oct; 18(1):335. PubMed ID: 37872602
[TBL] [Abstract][Full Text] [Related]
34. Epilepsy, neuropsychiatric phenotypes, neuroimaging findings, and genotype-neurophenotype correlation in 22q11.2 deletion syndrome.
AlKalaf HY; AlHashem AM; AlSaleh NS; AlJohar NM; Abo Thneen AM; ElGhezal HM; Bouhjar IB; Tlili-Graiess K; Sahari AH; Tabarki BM
Neurosciences (Riyadh); 2020 Aug; 25(4):287-291. PubMed ID: 33130809
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and treatment of psychiatric disorders other than psychosis in children and adolescents with 22q11DS: Examining associations with social and role functioning.
Armando M; Lin A; Pontillo M; Vicari S
Psychiatry Res; 2017 Aug; 254():238-243. PubMed ID: 28477546
[TBL] [Abstract][Full Text] [Related]
36. Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome.
Green T; Gothelf D; Glaser B; Debbane M; Frisch A; Kotler M; Weizman A; Eliez S
J Am Acad Child Adolesc Psychiatry; 2009 Nov; 48(11):1060-1068. PubMed ID: 19797984
[TBL] [Abstract][Full Text] [Related]
37. Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: Convergence with idiopathic psychosis and effects of deletion size.
Sun D; Ching CRK; Lin A; Forsyth JK; Kushan L; Vajdi A; Jalbrzikowski M; Hansen L; Villalon-Reina JE; Qu X; Jonas RK; van Amelsvoort T; Bakker G; Kates WR; Antshel KM; Fremont W; Campbell LE; McCabe KL; Daly E; Gudbrandsen M; Murphy CM; Murphy D; Craig M; Vorstman J; Fiksinski A; Koops S; Ruparel K; Roalf DR; Gur RE; Schmitt JE; Simon TJ; Goodrich-Hunsaker NJ; Durdle CA; Bassett AS; Chow EWC; Butcher NJ; Vila-Rodriguez F; Doherty J; Cunningham A; van den Bree MBM; Linden DEJ; Moss H; Owen MJ; Murphy KC; McDonald-McGinn DM; Emanuel B; van Erp TGM; Turner JA; Thompson PM; Bearden CE
Mol Psychiatry; 2020 Aug; 25(8):1822-1834. PubMed ID: 29895892
[TBL] [Abstract][Full Text] [Related]
38. Eye gaze during face processing in children and adolescents with 22q11.2 deletion syndrome.
Glaser B; Debbané M; Ottet MC; Vuilleumier P; Zesiger P; Antonarakis SE; Eliez S
J Am Acad Child Adolesc Psychiatry; 2010 Jul; 49(7):665-74. PubMed ID: 20610136
[TBL] [Abstract][Full Text] [Related]
39. Trajectories of psychiatric diagnoses and medication usage in youth with 22q11.2 deletion syndrome: a 9-year longitudinal study.
Kates WR; Mariano MA; Antshel KM; Chandra S; Gamble H; Giordano M; MacMaster E; Mattar M; St Fleur D; Faraone SV; Fremont WP
Psychol Med; 2019 Aug; 49(11):1914-1922. PubMed ID: 30226117
[TBL] [Abstract][Full Text] [Related]
40. Mitochondria in complex psychiatric disorders: Lessons from mouse models of 22q11.2 deletion syndrome: Hemizygous deletion of several mitochondrial genes in the 22q11.2 genomic region can lead to symptoms associated with neuropsychiatric disease.
Devaraju P; Zakharenko SS
Bioessays; 2017 Feb; 39(2):. PubMed ID: 28044359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
